Kornitzer Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.55M Buy
23,164
+21,164
+1,058% +$6.9M 0.15% 169
2025
Q1
$540K Buy
+2,000
New +$540K 0.01% 417
2023
Q4
Sell
-22,000
Closed -$3.9M 467
2023
Q3
$3.9M Hold
22,000
0.08% 261
2023
Q2
$4.18M Buy
+22,000
New +$4.18M 0.08% 264
2023
Q1
Sell
-1,080
Closed -$257K 484
2022
Q4
$257K Hold
1,080
0.01% 485
2022
Q3
$216K Buy
+1,080
New +$216K ﹤0.01% 498
2022
Q2
Sell
-3,360
Closed -$549K 501
2022
Q1
$549K Hold
3,360
0.01% 473
2021
Q4
$570K Hold
3,360
0.01% 479
2021
Q3
$634K Hold
3,360
0.01% 484
2021
Q2
$570K Sell
3,360
-2,400
-42% -$407K 0.01% 484
2021
Q1
$813K Sell
5,760
-56,345
-91% -$7.95M 0.01% 444
2020
Q4
$8.07M Sell
62,105
-32,410
-34% -$4.21M 0.14% 223
2020
Q3
$13.8M Buy
94,515
+33,202
+54% +$4.83M 0.27% 136
2020
Q2
$9.08M Buy
61,313
+54,593
+812% +$8.09M 0.18% 183
2020
Q1
$731K Hold
6,720
0.02% 414
2019
Q4
$774K Sell
6,720
-1,900
-22% -$219K 0.01% 439
2019
Q3
$693K Sell
8,620
-1,030
-11% -$82.8K 0.01% 421
2019
Q2
$700K Hold
9,650
0.01% 433
2019
Q1
$902K Hold
9,650
0.02% 394
2018
Q4
$704K Sell
9,650
-15,947
-62% -$1.16M 0.01% 404
2018
Q3
$2.24M Sell
25,597
-218,547
-90% -$19.1M 0.04% 309
2018
Q2
$24M Buy
244,144
+30,329
+14% +$2.99M 0.4% 95
2018
Q1
$25.5M Buy
213,815
+2,360
+1% +$281K 0.44% 85
2017
Q4
$26.9M Buy
211,455
+48,620
+30% +$6.18M 0.46% 74
2017
Q3
$19.1M Buy
+162,835
New +$19.1M 0.33% 99
2016
Q4
Sell
-91,560
Closed -$6.21M 469
2016
Q3
$6.21M Sell
91,560
-86,900
-49% -$5.89M 0.11% 232
2016
Q2
$9.9M Buy
178,460
+68,300
+62% +$3.79M 0.18% 179
2016
Q1
$6.92M Buy
110,160
+19,010
+21% +$1.19M 0.12% 230
2015
Q4
$8.58M Buy
91,150
+35,150
+63% +$3.31M 0.14% 214
2015
Q3
$4.5M Buy
56,000
+14,450
+35% +$1.16M 0.07% 254
2015
Q2
$4.98M Sell
41,550
-115
-0.3% -$13.8K 0.07% 264
2015
Q1
$4.35M Sell
41,665
-425
-1% -$44.4K 0.05% 268
2014
Q4
$4.08M Sell
42,090
-17,860
-30% -$1.73M 0.05% 266
2014
Q3
$4.68M Hold
59,950
0.05% 254
2014
Q2
$3.79M Buy
59,950
+7,975
+15% +$504K 0.04% 277
2014
Q1
$3.49M Buy
+51,975
New +$3.49M 0.04% 296